SAT-506 Rare Case of Durvalumab-Induced Thyroiditis, Transient Secondary Adrenal Insufficiency and Autoimmune Diabetes

Introduction: Cancer Immunotherapy (CI) is rapidly advancing field with different immune check point inhibitors (ICPi) targeting different cancers, with Durvalumab being one of the recent ICPi. Durvalumab induced endocrinopathies are common, mostly irreversible and if managed appropriately do not re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorantla, Yamuna, Amblee, Ambika, Lee, Yee Liong, Yap, Sara Elizabeth T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208712/
http://dx.doi.org/10.1210/jendso/bvaa046.973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208712/
http://dx.doi.org/10.1210/jendso/bvaa046.973

Ejemplares similares